Cargando…
Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study
BACKGROUND AND AIM: MDM4, a negative regulator of the p53 tumor suppression pathway, has been demonstrated to be overexpressed in a variety of human cancers. Research has revealed that the rs4245739 A>C polymorphism of MDM4 in the 3’-untranslated region makes it a miR-191 target site, leading to...
Autores principales: | Khanlou, Ziba Mohammad, Pouladi, Nasser, Feizi, Mohammadali Hosseinpour, Pedram, Negar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494227/ https://www.ncbi.nlm.nih.gov/pubmed/28547953 http://dx.doi.org/10.22034/APJCP.2017.18.4.1133 |
Ejemplares similares
-
Evaluating the association of rs6983267 polymorphism of the CCAT2 gene with thyroid cancer susceptibility in the Iranian Azeri population
por: Jabraili, Masoud, et al.
Publicado: (2023) -
Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer
por: Pouladi, Nasser, et al.
Publicado: (2019) -
Association of MDM4 Gene rs4245739 Polymorphism with the Risk and Clinical Characteristics of Colorectal Cancer in a Chinese Han Population
por: Zhao, De-Ming, et al.
Publicado: (2020) -
The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis
por: Chen, Jian, et al.
Publicado: (2022) -
The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk
por: Fan, Chuanbo, et al.
Publicado: (2014)